In addition, DUXAP10 essentially participates in ESCC development and progression by enhancing cell proliferation and metastasis, accelerating cell cycle progression, and hindering cell apoptosis in KYSE30 and KYSE180 cells. Here, DUXAP10 is linked to esophageal squamous cell carcinoma.